Perry, Iowa
October 25, 2007
Mark Seed Company is pleased to announce that their U.S.
patent was issued on July 10, 2007, entitled “Process for
controlling Cyst Nematode population in soybeans”; patent Number
7,241,938. The patent comes after more than ten years of lab and
field testing. Mark Seed Company, an agricultural sales company,
specializes in soybean research and development.
Soybean Cyst Nematodes (SCN) is a global problem and the leading
cause of yield loss in the soybean industry today. SCN are
parasitic organisms that live in the soil and attach themselves
to soybean roots preventing plants from receiving nutrients.
Traditional methods used today of rotating corn and soybean
plantings and using current SCN resistant technology aren’t
working. SCN are able to shift their race. This shift makes them
resistant to the very methods used to create resistance and the
populations of nematodes continue to climb.
Results of a multi-year Soybean Cyst Nematode (SCN) study have
proven a new technology in the industry can lower SCN counts in
the soil and maintain race 3 environments. The study was
conducted by Mark Seed Company to provide “proof of concept” of
Mark Seed’s newly patented technology, Cyst Tech® Soybeans.
Tests were conducted from 2003 to 2006 to measure Cyst Tech®
soybean’s ability to reduce SCN in the soil and maintain race 3
in the field. A rotation alternating Mark Seed’s CTA and CTB
lines for a period of four consecutive years in an open field
study resulted in lower SCN populations. SCN counts dropped from
30,000 eggs to 675 eggs per 100cc of soil.
Dr. Ralph von Qualen of ACTS, Inc (an independent plant
pathology laboratory in Carroll, Iowa and an expert in
nematology) did the egg counts and race tests on soil samples
provided by Mark Seed Company. Race tests on soil from different
rotation sequences showed that all the SCN populations could be
described as race 3 in 2006 tests.
Less nematodes to fight in the fields means more yields for
farmers.
Cyst Tech can be used in all soybean markets, including
bio-diesel fuels, GMO, conventional, organic, and modified oil
soybean lines. It’s the company’s first issued U.S. patent for
this technology.
“This is an incredible opportunity for our company to offer this
patented technology to our nation’s farmers,” says Mark
Terpstra, Cyst Tech® inventor and CEO of Mark Seed Company. “The
implications of controlling SCN are huge and the first and only
of its kind. We truly believe that this technology will
revolutionize the soybean industry.”
The accomplishment is also important to the town of Perry. “As
mayor, I want to congratulate Mr. Terpstra. It is gratifying to
see his creativity and dedication being recognized,” says Mayor
Vivi Shirley. “This process will probably increase soybean
yields tremendously and will have huge implications for
biofuels. This may very well put our city, Perry, on the world
map.”
|
In the August IPSA newsletter, Mark Seed Company
submitted the following information incorrectly:
EXTRACTION: “Dr. von Qualen conducted a multi-year,
independent study that proved that Cyst Tech® was
able to significantly lower SCN counts and control
race shifting.”
INSERTION: Results of a multi-year Soybean Cyst
Nematode (SCN) study have proven a new technology in
the industry can lower SCN counts in soil and
maintain race 3 environments. The study was
conducted by Mark Seed Company to provide “proof of
concept” of Mark Seed’s newly patented technology,
Cyst Tech® Soybeans. Tests were conducted from 2003
to 2006 to measure Cyst Tech® soybean’s ability to
reduce SCN in the soil and maintain race 3 in the
field. A rotation alternating Mark Seed’s CTA and
CTB lines for a period of four consecutive years in
an open field study resulted in lower SCN
populations. SCN counts dropped from 30,000 eggs to
675 eggs per 100cc of soil. Dr. Ralph von Qualen of
ACTS, Inc (an independent plant pathology laboratory
in Carroll, Iowa) did the egg counts and race test
on soil samples provided by Mark Seed Company. Race
tests on soil from different rotation sequences
showed that all the SCN populations could be
described as race 3 in 2006 tests. |
|
|
